MX-6043

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMX-6043
Drug Alias NamePPARgamma antagonist (Maxia)MX-6043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor modulatorsInsulin sensitizersPeroxisome proliferator-activated receptor γ inhibitors
TargetsPeroxisome proliferator-activated receptor γRetinoid X receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxia Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A